Myositis Treatment Market Size

Myositis Treatment Market size was valued at USD 650 Million in 2023 and is projected to exceed USD 1.1 Billion by the end of 2036, expanding at over 4.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of myositis treatment is evaluated at USD 686.2 Million.. The major factor for market growth is the rising cases of myositis among the global population. For instance, in the United States, an estimated 1,600 to 3,200 new cases of myositis are detected every year. Also, it has been observed that 50,000 to 75,000 people are already being diagnosed and living with myositis in the same region. Thus, the rising cases of myositis are expected to generate demand for its treatment and expand its market size during the forecast period.

The global myositis treatment market is attributed to growth on account of rising inflammation in muscles owing to infection, injury, and autoimmune disease across the world. Furthermore, the prevalence of viral infections and high consumption rate of statins, cocaine, and alcohol is aiding myositis in the global population and the expansion of the market size during the assessment period. Also, the burgeoning geriatric population who are more prone to inflammation in muscles and other musculoskeletal diseases is expected to increase the demand for myositis treatment in the world. In addition to the other factors mentioned, the increasing awareness level about myositis disease along with its different types, symptoms, causes, and others, and the easy availability of treatment and cure procedures is also estimated to bring in lucrative growth opportunities for the market growth. Moreover, the recent advancement in technology has propelled a faster production rate of novel drugs and medical devices and is projected to impetus a significant revenue generation from the global myositis treatment market during the forecast period. The emergence of new modern therapies in the healthcare industry along with the high investments by major key players to bridge the gap between supply and demand of medications and therapies is also anticipated to create a positive outlook for market growth.